Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Respir Physiol Neurobiol ; 223: 49-58, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26777422

RESUMO

The present study provides an accurate simulation of velocity and temperature distributions of inhalation thermal injury in a human upper airway, including vestibule, nasal cavity, paranasal sinuses, nasopharynx, oropharynx, larynx, and upper part of main bronchus. To this end, a series of CT scan images, taken from an adult woman, was used to construct a three dimensional model. The airway walls temperature was adjusted according to existing in vivo temperature measurements. Also, in order to cover all breathing activities, five different breathing flow rates (10, 15, 20, 30, and 40 l/min) and different ambient air temperatures (100, 200, 300, 400, and 500 °C) were studied. Different flow regimes, including laminar, transitional, and turbulence were considered and the simulations were validated using reliable experimental data. The results show that nostrils, vestibule, and nasal cavity are damaged more than other part of airway. Finally, In order to obtain the heat flux through the walls, correlations for Nusselt number for each individual parts of airway (vestibule, main upper airway, nasopharynx etc.,) are proposed.


Assuntos
Queimaduras por Inalação/fisiopatologia , Simulação por Computador , Temperatura Alta/efeitos adversos , Laringe/lesões , Cavidade Nasal/lesões , Faringe/lesões , Fenômenos Fisiológicos Respiratórios , Adulto , Feminino , Humanos
2.
Int J Gynaecol Obstet ; 15(3): 216-20, 1977.
Artigo em Inglês | MEDLINE | ID: mdl-611024

RESUMO

Tne patients with galactorrhea syndrome were treated with two different daily dosages (5 mg and 7.5 mg) of Bromergocryptine. The 5 mg daily dosage often did not produce the desired hormonal and clinical response. Five patients were treated with this regimen for 38 to 90 days, with treatment extending over more than one menstrual cycle. However, the 7.5 mg daily dosage resulted in complete cessation of galactorrhea in all patients, restoration of menstrual cycles in five patients, and pregnancies in four patients. Disappearance of lactation proved to be a very good indicator of the general responsiveness of patients. Nausea, vomiting, and occasional dizziness were side effects of the drug. The case histories and hormonal findings of four typical patients are reported.


Assuntos
Bromocriptina/uso terapêutico , Galactorreia/tratamento farmacológico , Transtornos da Lactação/tratamento farmacológico , Bromocriptina/administração & dosagem , Bromocriptina/efeitos adversos , Relação Dose-Resposta a Droga , Feminino , Galactorreia/metabolismo , Humanos , Menstruação , Gravidez , Síndrome
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...